Furthermore, patients with anti‐ACE2 IgM experienced more inflammatory arthritis, RP‐ILD, and worse FVC, all of which approached statistical significance (P ~ 0.05) despite the small number of patients. This evidence concerns the gene CD40LG and interstitial lung disease.